EUVIMEDEUVIMED entdecken
Open Access

HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA

Wenbo Jia, Liang Yu, Bin Xu, Yanzhi Feng, Jinyi Wang, Deming Zhu, Chao Xu, Litao Liang, Yongping Zhou, Lianbao Kong, Wenzhou Ding

International Journal of Biological Sciences · 2024 · 20 (13) · 5087-5108

DOI: 10.7150/ijbs.95276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Wenbo Jia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA-Binding Proteins, Hepatocyte Nuclear Factor 4. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRNA-Binding ProteinsHepatocyte Nuclear Factor 4HumansRNA, Long NoncodingMaleRNA, MessengerCell Line, TumorFemaleUbiquitinGene Expression Regulation, NeoplasticAnimalsMiddle AgedMiceDisease ProgressionCell ProliferationRNA StabilityMice, Nude

Stichwörter der Autor:innen

AGR2.HNF4A-AS1Hepatocellular carcinomaPCBP2ubiquitination

Substanzen

RNA-Binding ProteinsHepatocyte Nuclear Factor 4PCBP2 protein, humanRNA, Long NoncodingRNA, MessengerUbiquitinHNF4A protein, human

Autor:innen und Institutionen

  • Hepatobiliary Centre, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, National Health Commission (NHC) Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), Nanjing, Jiangsu Province…
  • Department of General Surgery, the Second Affiliated Hospital of Anhui Medical University, China.
  • Department of Hepatobiliary, Jiangnan University Medical Center, JUMC, China.

Zitieren

APA

Jia, W., Yu, L., Xu, B., Feng, Y., Wang, J., Zhu, D., Xu, C., Liang, L., Zhou, Y., Kong, L., & Ding, W. (2024). HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA. International Journal of Biological Sciences, 20(13), 5087-5108. https://doi.org/10.7150/ijbs.95276

Vancouver

Jia W, Yu L, Xu B, Feng Y, Wang J, Zhu D, et al. HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA. International Journal of Biological Sciences. 2024;20(13):5087-5108. doi:10.7150/ijbs.95276

BibTeX
@article{Jia2024,
  author = {Jia, Wenbo and Yu, Liang and Xu, Bin and Feng, Yanzhi and Wang, Jinyi and Zhu, Deming and Xu, Chao and Liang, Litao and Zhou, Yongping and Kong, Lianbao and Ding, Wenzhou},
  title = {HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  volume = {20},
  number = {13},
  pages = {5087--5108},
  doi = {10.7150/ijbs.95276}
}
Kostenlos starten →